-0.027 (-13.43%)
Range 0.165 - 0.209   (26.67%)
Open 0.207
Previous Close 0.201
Buy Price 0.172
Buy Volume 9
Sell Price 0.173
Sell Volume 10
Volume 72,246,596
Value -
Measurement Type Value
EPS (USD) -1.315
Trailing EPS (USD) -0.987
NAV (USD) -0.634
Cash In Hand (USD) 0.246
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV -0.525
Price / Cash In Hand 1.354
Issued & Paid-up Shares 92,817,500
Treasury Shares -
Market Cap (M) 30.927
Par Value (USD) n.a.
Beta - 75 Days 0.565
R-Squared - 75 Days(%) 1.37
Beta - 500 Days 0.233
R-Squared - 500 Days(%) -
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 16 Oct 2021 04:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date 11 Nov 2021
View All Events


IGI Laboratories, Inc. is a specialty generic pharmaceutical company. Under its IGI label, the Company sells generic topical pharmaceutical products that are bioequivalent to their brand name counterparts. The Company provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. The Company has two platforms for growth: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. The Company also develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as the OTC and cosmetic markets. These products are used in a range of applications from cosmetics to the prescription treatment of conditions like dermatitis, psoriasis and eczema.

Loading Chart...